AstraZeneca anticancer drug Trastuzumab Deruxtecan protocol amendment proposal approved by CDSCO panel Roshni Dhar23 Aug 2022 1:00 PM GMTBased on the justification provided by the pharma major AstraZeneca, the Subject Expert Committee(SEC) functional under Central Drug Standard Control...
CDSCO issues alert on Baxter Blood Purification Device Hemoperfusion Cartridge Rahul Verma2 Aug 2022 6:39 AM GMTIn suspecting the presence of particulate matter, Central Drug Standard Control Organization (CDSCO) has issued medical devices alert on Baxter...
CDSCO panel nod to Novartis Ruxolitinib for acute and chronic graft versus host disease Rahul Verma24 July 2022 8:45 AM GMTIn response to the pharma major Novartis proposal for additional indication of Ruxolitinib Tablets 5/10/15/20 mg, the Subject Expert Committee (SEC)...
Maha: FDA asks medical device manufacturers to register under Medical Devices Rules 2017 Adity Saha16 Feb 2022 6:11 AM GMTNagpur: The Food and Drug Administration (FDA) has issued a notice following instructions from the Central Drug Standard Control Organization (CDSCO),...
